Match!
Venkata R. Satyam
Internal medicineZoster vaccineDiabetes mellitusGeneral surgeryMedicine
3Publications
0Citations
What is this?
Publications 6
Newest
Source
#1W. Thomas Clarke (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 18
#2Venkata R. Satyam (BU: Boston University)
Last. Joseph D. Feuerstein (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 14
view all 8 authors...
Source
#1Venkata R. Satyam (BU: Boston University)
#2Pei-Hsuan Li (BU: Boston University)
Last. Francis A. Farraye (BU: Boston University)H-Index: 49
view all 7 authors...
Patients with inflammatory bowel disease (IBD) are at increased risk of developing herpes zoster. In October 2017, the FDA approved a two-dose adjuvanted, recombinant herpes zoster vaccine (RZV). There is a theoretical concern that vaccine adjuvants may cause flares in patients with immune-mediated diseases. We aimed to assess the rates of IBD flare and adverse reactions after administration of RZV in a cohort of patients with IBD. We conducted a prospective observational study of patients with ...
2 CitationsSource
Source
Source
Source
1